| |
|
|
|
vTv Therapeutics Inc.  
|
|
0.82 0 (0%) |
09-21 09:46 |
|
Open: |
0.8145 |
Pre close: |
0.82 |
Target:
|
1.21
|
|
High: |
0.82 |
Low: |
0.8007 |
Resistance:
|
1.03
1.25
|
|
Volume: |
11,187 |
Market Cap: |
30M |
Support:
|
0.68
0.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.79
 |
MACD |
MACD(12,26):
|
-0.11  |
|
MA(20): |
0.99 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
1.43 |
Stochastic Oscillator |
%K(14,3):
|
26.56 |
|
MA(250): |
3.77 |
%D(3): |
19.18 |
|
Average Volume(K) |
3-Month: |
12791
|
52-Week |
High:
|
8.40 |
|
10-Days: |
22669 |
Low: |
0.65 |
|
RSI |
RSI(14):
|
34.72 |
Change(%): |
-86.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.410 |
Return on Equity (ttm) |
15.5 |
Shares Out. (M) |
36.99 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-58.5 |
Shares Float (M) |
36.87 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
18923.1 |
% Held by Institutions |
12.90 |
|
Forward EPS |
-1.728 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
730 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.310 |
P/E |
-0.58 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-32.83 |
P/S |
20098366.00 |
|
Operating Margin |
-884.12 |
Levered Free Cash Flow
(M) |
-12.99 |
P/CF |
-0.92 |
|
|
|
|
|
|
